United States · Series E startup

Who invested in Ginkgo Bioworks

5 rounds we have observed, with the 14 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Y Combinator: S14

Funding summaryUpdated 26 Oct 2026

$444Mraised across 5 rounds since 2014, from 5 sources

$120KSeed$9.0MSeries A$45MSeries B$100MSeries C$290MSeries E
Latest round
Series E, $290MSept 2019
Step-upi
2.9×
Investors
14
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20152016201720182019
$120KSeed$9.0MSeries A$45MSeries B$100MSeries C$290MSeries E
First round
Seed, $120K
Jul 2014
Biggest round
$290M
Series E · Sept 2019
Usual gap between rounds
11 months
the median of 4

The rounds

  1. Sept 2019
    Series E$290M

    No investor was named in the report.

    Reported by FinSMEs

  2. Jun 2016
    Series C$100M2 new

    Reported by TechCrunch

  3. Jul 2015
    Series B$45M1 new2 returning

    From a historical funding recordSEC filing: $50M sold, first sale Jul 2015

  4. Mar 2015
    Series A$9.0M6 new

    From a historical funding record

  5. Jul 2014

Founders and team

From the SEC filings it signed: 3 on the team.

  • Bartholomew CantonExecutive Officeri
  • Jason KellyDirector, Executive Officeri
  • Reshma ShettyDirector, Executive Officeri

On the board, as filediPeter Boynton

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

FelicisVC firm2rounds
OS FundVC firm2rounds
Y CombinatorAccelerator1round
DCVCVC firm1round
TEEC Angel FundVC firm1round
Allen & CompanyWealth manager1round
Viking GlobalVC firm1round
Farzad (Zod) NazemVC firm1round
China Rock CapitalVC firm1round
Vast VenturesVC firm1round
iGlobe PartnersVC firm1round
David SpectorAngel1round
Ken ArnoldVC firm1round
Ballie GiffordGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 12 firms list Ginkgo Bioworks as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Innovation EndeavorsVC firmPer its own site
MassVenturesVC firmPer its own site
TSVCVC firmPer its own site
Prelude VenturesVC firmPer its own site
11.2 CapitalVC firmPer its own site
ReshapeVC firmPer its own site
Brightwing CapitalVC firmPer its own site
Cannage CapitalVC firmPer its own site
CatapultVC firmPer its own site
Cool Climate CollectiveAngel networkPer its own site
Next VenturesVC firmPer its own site
PetriVC firmPer its own site

Quick answers about Ginkgo Bioworks

Who invested in Ginkgo Bioworks?

Ginkgo Bioworks's investors include Felicis, OS Fund, Y Combinator, DCVC and TEEC Angel Fund, and 9 more on record.

How much has Ginkgo Bioworks raised?

Ginkgo Bioworks has raised $444M across 5 rounds since 2014.

When did Ginkgo Bioworks last raise?

Ginkgo Bioworks's most recent round was a Series E of $290M in Sept 2019.

What was Ginkgo Bioworks's biggest round?

Its most recent round, $290M in Sept 2019, is also its largest on record.

Who backed Ginkgo Bioworks first?

Ginkgo Bioworks's first round on record, in Jul 2014, was backed by Y Combinator, TEEC Angel Fund and Farzad (Zod) Nazem and 2 others.

What stage is Ginkgo Bioworks at?

Ginkgo Bioworks's latest named round is a Series E, in Sept 2019.

Where is Ginkgo Bioworks based?

Ginkgo Bioworks is based in the United States.

Companies like Ginkgo Bioworks

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.